Stipan Jonjic
Stipan Jonjic
Professor and Chair, Department of Histology and Embryology, Faculty of Medicine, University of Rijeka
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, M Akdis, I Andrä, F Annunziato, ...
European journal of immunology 47 (10), 1584-1797, 2017
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
N Stanietsky, H Simic, J Arapovic, A Toporik, O Levy, A Novik, Z Levine, ...
Proceedings of the National Academy of Sciences 106 (42), 17858-17863, 2009
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.
MJ Reddehase, F Weiland, K Münch, S Jonjic, A Lüske, UH Koszinowski
Journal of virology 55 (2), 264-273, 1985
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack
C Gur, Y Ibrahim, B Isaacson, R Yamin, J Abed, M Gamliel, J Enk, ...
Immunity 42 (2), 344-355, 2015
Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
B Polić, H Hengel, A Krmpotić, J Trgovcich, I Pavić, P Lučin, S Jonjić, ...
The Journal of experimental medicine 188 (6), 1047-1054, 1998
Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.
S Jonjić, W Mutter, F Weiland, MJ Reddehase, UH Koszinowski
The Journal of experimental medicine 169 (4), 1199-1212, 1989
Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution
M Wagner, S Jonjić, UH Koszinowski, M Messerle
Journal of virology 73 (8), 7056-7060, 1999
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.
S Jonjić, I Pavić, B Polić, I Crnković, P Lucin, UH Koszinowski
The Journal of experimental medicine 179 (5), 1713-1717, 1994
Pathogenesis of murine cytomegalovirus infection
A Krmpotic, I Bubic, B Polic, P Lucin, S Jonjic
Microbes and Infection 5 (13), 1263-1277, 2003
Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.
P Lucin, I Pavić, B Polić, S Jonjić, UH Koszinowski
Journal of virology 66 (4), 1977-1984, 1992
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
MJ Reddehase, M Balthesen, M Rapp, S Jonjić, I Pavić, UH Koszinowski
The Journal of experimental medicine 179 (1), 185-193, 1994
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo
A Krmpotić, DH Busch, I Bubić, F Gebhardt, H Hengel, M Hasan, ...
Nature immunology 3 (6), 529-535, 2002
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.
S Jonjić, I Pavić, P Lucin, D Rukavina, UH Koszinowski
Journal of virology 64 (11), 5457-5464, 1990
Gain of virulence caused by loss of a gene in murine cytomegalovirus
I Bubić, M Wagner, A Krmpotić, T Saulig, S Kim, WM Yokoyama, S Jonjić, ...
Journal of virology 78 (14), 7536-7544, 2004
Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes
A Saalmüller, MJ Reddehase, HJ Bühring, S Jonjić, UH Koszinowski
European journal of immunology 17 (9), 1297-1301, 1987
Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor
P Lucin, S Jonjic, M Messerle, B Polic, H Hengel, UH Koszinowski
Journal of General Virology, 101-110, 1994
Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1
J Crouse, G Bedenikovic, M Wiesel, M Ibberson, I Xenarios, D Von Laer, ...
Immunity 40 (6), 961-973, 2014
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-γ signaling and antiviral responses
A Zimmermann, M Trilling, M Wagner, M Wilborn, I Bubic, S Jonjic, ...
The Journal of experimental medicine 201 (10), 1543-1553, 2005
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145
A Krmpotic, M Hasan, A Loewendorf, T Saulig, A Halenius, T Lenac, ...
The Journal of experimental medicine 201 (2), 211-220, 2005
Mouse TIGIT inhibits NK‐cell cytotoxicity upon interaction with PVR
N Stanietsky, TL Rovis, A Glasner, E Seidel, P Tsukerman, R Yamin, ...
European journal of immunology 43 (8), 2138-2150, 2013
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20